Study of Aclidinium Bromide/Formoterol Fumarate Compared With Salmeterol/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Clinical trial NCT01908140 · COMPLETED
Trial details
- NCT number
- NCT01908140
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2014-08-01
- Enrollment
- 933
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.